The overall emerging technologies sector is comprised of a variety of fast growing and independent segments. For completeness, the current and forecasted markets are comprised of the total market opportunity for each respective segment. Within each subsection, there is a detailed forecast for each driving mechanism, or relevant area of growth.
Information to prepare this report was obtained from participating and emerging companies in the emerging technologies area; American Heart Association; the National Heart, Lung, and Blood Institute; articles published in medical journals such as American Heart Journal, Circulation, Journal of Emerging Technologies Pharmacology, Lancet, and others; the World Health Organization and other government agencies; literature searches; annual reports; 10Ks; and others. Population estimates are based on those reported by the international data base of the U.S. Census Bureau.
Current and historical revenue figures for individual products have been sourced from company disclosures that exist in the public domain or from government sources.
CHAPTER ONE: INTRODUCTION 1
STUDY GOALS AND OBJECTIVES 1
REASONS FOR DOING THE STUDY 1
SCOPE OF REPORT 2
INTENDED AUDIENCE 3
METHODOLOGY AND INFORMATION SOURCES 3
RELATED REPORTS 4
BCC ONLINE SERVICES 4
CHAPTER TWO: SUMMARY 6
SUMMARY TABLE GLOBAL EMERGING TECHNOLOGIES
FORECAST BY AREA, THROUGH 2015 ($ MILLIONS) 6
SUMMARY FIGURE GLOBAL EMERGING TECHNOLOGIES
FORECAST BY AREA, 2009-2015 ($ MILLIONS) 7
SUMMARY (CONTINUED) 8
CHAPTER THREE: THERAPEUTIC VACCINES 9
TABLE 1 GLOBAL MARKET FOR THERAPEUTIC VACCINES,
THROUGH 2010 ($ MILLIONS) 9
KEY EVENTS IN THE THERAPEUTIC VAC
Copyright©2010 PR Newswire.
All rights reserved